Delivery Order SPE2DR25D1109-SPE2DR26FFL6B
- Not listed
- The Defense Logistics Agency awarded a $16,130.19 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 tablets of Levorphanol 2 mg, with an ultimate completion date of January 29, 2026. This non-set-aside contract was competitively awarded and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company, Cencora, Inc., which holds a substantial Indefinite Delivery...
- The Defense Logistics Agency awarded a $2,715.74 delivery order to AmerisourceBergen Drug Corp for Levorphanol 2 mg tablets (100 count) under a firm fixed price contract. The order, issued on December 4, 2025, with an ultimate completion date of December 5, 2025, represents a non-competitive, non-set-aside award to supply this pharmaceutical product to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,606.83 to AmerisourceBergen Drug Corp for the supply of Levorphanol 2 mg tablets in quantities of 100 units. This firm fixed-price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by July 11, 2025. The contract will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Levorphanol 2 mg tablets (100-count units) with a ceiling value of $2.8K. This is a firm fixed-price delivery order with an ultimate completion date of August 1, 2025, and represents a non-competitive set-aside award. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $19,854.05 to AmerisourceBergen Drug Corp for the supply of Levorphanol 2 mg tablets in quantities of 100 units. This firm fixed-price contract was awarded on September 16, 2025, with an ultimate completion date of September 17, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a non-set-aside competitive award, reflecting AmerisourceBergen's capability...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Levorphanol 2 mg tablets in a quantity of 100 units on November 13, 2025. This firm fixed-price delivery order, valued at $2,715.74, is scheduled for completion by November 14, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award was made through competitive procurement with no set-aside designation. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a $3,071.22 delivery order to AmerisourceBergen Drug Corp for the supply of Levorphanol 2 mg tablets (100 count) under a firm fixed-price contract. The delivery order, issued on June 18, 2025, with an ultimate completion date of June 20, 2025, was competitively awarded with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $4,606.83 to AmerisourceBergen Drug Corp for the supply of Levorphanol 2 mg tablets (100 count) on July 25, 2025, with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Levorphanol is an opioid analgesic used for pain management in military and federal healthcare...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply Levorphanol Tablets 2mg. The contract has a potential value of $6,359.31 and a completion date of January 17, 2024. No set-aside designation was used. Amerisourcebergen Drug Corp, through its Corporate Office division, provides pharmaceutical products and services to U.S. government agencies,...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Levorphanol Tablets 2mg to the U.S. government. The contract, valued at $1,796.80, is a Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense. The contract has a firm fixed price and a completion date of June 20, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distribution company that holds a...
- SPE2DR25D1109Indefinite Delivery Contract
- SPE2DR25D1109-SPE2DR26FFL6BDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $20,092.82 to AmerisourceBergen Drug Corp for the supply of Levorphanol 2 mg tablets in quantities of 100 units. This firm fixed-price contract, issued on January 28, 2026, with an ultimate completion date of January 29, 2026, represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive pharmaceutical prime vendor agreement valued at up to $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems. The company maintains extensive federal contract vehicles with the Defense Logistics Agency and other government agencies, supplying a broad portfolio of prescription medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This delivery order for Levorphanol, an opioid pain management pharmaceutical, reflects the company's ongoing role in supporting the Defense Health Agency's medical supply requirements for military treatment facilities and related federal healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.1k | 1/27/26 |